MedPath

Connect Research Project: A trial of a trauma- and attachment-based intervention in kinship and foster care

Not Applicable
Recruiting
Conditions
Trauma-informed caregiving
Child behavioural and socioemotional functioning
Complex trauma
Mental Health - Other mental health disorders
Public Health - Other public health
Registration Number
ACTRN12617000946314
Lead Sponsor
The Australian National University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Children will be eligible to participate in the study if they are aged 8-16 years and have resided in their current home-based care placement for at least four weeks.

Caregivers will be eligible to participate if they are currently supporting a child in a kinship or foster care placement.

Exclusion Criteria

Families will be excluded from participating in the study based on child and/or kinship/foster carer characteristics. Exclusion criteria concerning children includes: currently in a crisis/emergency situation, severe mental illness (e.g., schizophrenia, bipolar disorder), significant physical health care needs, severe developmental disability, and/or severe intellectual disability. Families will also be excluded if carers have a severe mental illness or substance use problem, and are unable to speak sufficiently fluent English and/or have limited comprehension of English.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in children's dysregulated behaviour and emotions as measured by the Strengths and Difficulties Questionnaire and Affect Regulation Checklist. [Assessed at baseline, immediately post-intervention (10 weeks after baseline) and 6-month follow-up. ];Change in the quality of the caregiver-child relationship as measured by the Comprehensive Child-Parent Attachment Inventory and Revised Conflict Tactics Scale. [Assessed at baseline, immediately post-intervention (10 weeks after baseline) and 6-month follow-up. ]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath